Whitepaper - Pharmaceutical Executive

ADVERTISEMENT

Whitepaper

Prescriber Feedback System Generates 60% Lift in NRx

September 15, 2014

Would a 60% NRx increase be a benefit to your brand? With TrialCard’s Prescriber Feedback System, a launch brand in a competitive market helped prescribers gain positive-experience trials.

Risk-Based Monitoring for Late-Phase Research

September 12, 2014

The growing consensus among clinical researchers and regulatory authorities is that risk-based monitoring (RBM) is more likely to ensure patient protection and overall study quality and allows for monitoring that can be more effective than the traditional model of routine visits to all sites with 100% source data verification (SDV).

The Link Between Your Cold Chain and Your Bottom Line

September 2, 2014

A reliable and properly documented cold chain is critically important for pharmaceutical manufacturers. Shipping a product improperly can harm the patient and can also harm a manufacturer’s reputation and bottom line. This whitepaper discusses the role of documentation, details how to protect products, and provides a cold chain shopping checklist.

From Individuals to Institutions

September 1, 2014

In this article, Campbell Alliance details five best practices companies should follow as they shift from transactional selling to account management to address the needs of today’s new breed of organized customers.

Feeling Some ‘Side Effects’ from Health Reform

September 1, 2014

The following article compares various aspects of ACA exchanges with employer-sponsored plans to more closely examine benefit design and cost-sharing features that already are having an impact on patients nationwide. Breakaway Policy Strategies and Chandler Chicco Companies discuss these tradeoffs and provide communications recommendations for biopharmaceutical companies, advocacy groups and patients stepping up to make sure their voices are included.

A Plan for Provider Engagement: Improve Pharma Sales Force Effectiveness

August 15, 2014

Today, pharmaceutical brands are faced with two major growth challenges: reduced access to physicians and a limited sales team. In our latest article, pharma brands learn how to target their ideal prospects with effective, custom messaging through preferred and proven channels?thereby growing sales without expanding their team.

Harnessing Advanced Analytics to Increase Adherence and Improve Health Outcomes

August 1, 2014

Driving healthier outcomes has never been more important than it is today – and a significant factor is patient adherence to prescribed medications. Adheris Health's Alex Pedan explains how personalized messaging – shaped by data insights on patient preferences and behaviors – has the power to improve adherence from the start of a patient's therapy.

Market Profile of U.S. Internists

July 1, 2014

The Market Profile of U.S. Internists report provides actionable insights on internists, one of the top specialties in demand today. Use this OneKey report to help you better engage this group of physicians that treat and prescribe for a wide range of medical conditions.

Multichannel: Remote Interactions

July 1, 2014

Discover how a well-articulated multichannel strategy can provide the opportunity to more efficiently reach your customers all along the value chain, and generate superior returns. This paper will show the potential and opportunity of using remote interactions in multichannel campaigns to more efficiently communicate on health care outcomes, added value treatments and product benefits.

ADVERTISEMENT

Click here